Value of an enzymatic assay for the determination of serum ceruloplasmin.
The serum concentration of the copper protein ceruloplasmin has been an important diagnostic indicator of Wilson's disease (WD). It is widely quoted that 95% of people with WD have low serum ceruloplasmin concentrations. Current evidence suggests that a normal serum ceruloplasmin concentration is more common in patients with WD, particularly those with liver disease, perhaps in part because of the routine use of an immunologic assay. This assay might indicate a normal level of ceruloplasmin when the enzymatic activity is lower. Enzymatic activity is the biologically relevant parameter. We compared the immunologic measurement with the enzymatic assessment of oxidase activity in patients with liver or neurologic symptoms of unknown origin in whom WD was considered in the differential diagnosis. Although a strong correlation of ceruloplasmin protein concentration with oxidase activity was observed in controls, this was not the case for these patients. Twelve patients, presenting with various types of hepatic disease, demonstrated a weak correlation between ceruloplasmin protein concentration and oxidase activity. Ten percent of patients with neurologic symptoms ( n = 41) had low ceruloplasmin concentrations and oxidase activity, and another 8% had normal ceruloplasmin concentrations associated with low oxidase activity. Although the enzymatic method is preferred for its biologic relevance, ceruloplasmin analysis is not a reliable diagnostic parameter for the diagnosis of WD in patients with liver disease. An important use of the ceruloplasmin oxidase assay is in the follow-up of patients with WD. Ceruloplasmin oxidase activity was undetectable in sera from patients with WD who were undergoing long-term chelation therapy, suggesting an early sign of copper depletion and a need for subsequent monitoring for symptoms of copper deficiency.
Macintyre
Georgina
G
Department of Medical Genetics, University of Alberta, Edmonton, Canada.
Gutfreund
Klaus S
KS
Martin
W R Wayne
WR
Camicioli
Richard
R
Cox
Diane W
DW
D002570:Ceruloplasmin / Q000032:analysis* / Q000378:metabolism*; D002614:Chelating Agents / Q000008:administration & dosage; D003300:Copper / Q000097:blood; D004492:Edetic Acid; D005069:Evaluation Studies as Topic; D005260:Female; D006527:Hepatolenticular Degeneration / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D007124:Immunoenzyme Techniques / Q000379:methods*; D008297:Male; D010396:Penicillamine / Q000008:administration & dosage; D010949:Plasma
D002614:Chelating Agents; D003300:Copper; D004492:Edetic Acid; D002570:Ceruloplasmin; D010396:Penicillamine